About
Technology
Issues
FAQ
Links
Official Page
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
